Atlas Trials

Recurrent Central Nervous System Lymphoma

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Central Nervous System Lymphoma

RecordFirmDate
Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma (NCT03770416)M.D. Anderson Cancer Center2019-02-15
Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma (NCT03558750)Vanderbilt-Ingram Cancer Center2018-06-14
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas (NCT03277729)Fred Hutchinson Cancer Center2017-12-05

Track Recurrent Central Nervous System Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.